详细信息
背景信息
What is this antibody validated in? Anti-HDAC1 antibody [EPR460(2)] (ab109411) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples. What is the molecular weight of HDAC1? Anti-HDAC1 [EPR460(2)] (ab109411) specifically detects a band for HDAC1 (UniProt: Q13547) at a molecular weight of 55kDa. Trusted by the scientific community Anti-HDAC1 [EPR460(2)] (ab109411) was first used in a scientific publication in 2011 and has been cited over 30 times in peer-reviewed journals. Reviewed by scientists Anti-HDAC1 [EPR460(2)] (ab109411) has over 5 independent reviews from customers. Specificity confirmed The specificity of Anti-HDAC1 antibody [EPR460(2)] (ab109411) has been confirmed by Western blot testing in HDAC1 Knockout HAP1 cells. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
文献引用 (66)
Rapid degradation of histone deacetylase 1 (HDAC1) reveals essential roles in both gene repression and active transcription
组蛋白去乙酰化酶 1 (HDAC1) 的快速降解揭示了其在基因抑制和活性转录中的重要作用
Acetylation-regulated DUSP1 deficiency contributes to renal fibrosis progression.
乙酰化调控的 DUSP1 缺乏会导致肾纤维化进展
Chidamide enhances the sensitivity of gastric cancer to 5-fluorouracil chemotherapy by suppressing the HDAC3/HNF4A/TYMS axis.
西达米德通过抑制 HDAC3/HNF4A/TYMS 轴增强胃癌对 5-氟尿嘧啶化疗的敏感性。
Modulation of CREB3L2-ATF4 heterodimerization via proteasome inhibition and HRI activation in Alzheimer's disease pathology.
阿尔茨海默病病理中蛋白酶体抑制和HRI激活对CREB3L2-ATF4异二聚体的调节
Generation and validation of a novel multitarget small molecule in glioblastoma.
胶质母细胞瘤新型多靶点小分子的生成与验证
c-Ski is a novel repressor of NF-κB through interaction with p65 and HDAC1 in U937 cells.
c-Ski 是 U937 细胞中通过与 p65 和 HDAC1 相互作用而抑制 NF-κB 的新型抑制剂
Knockdown of RUVBL2 improves hnRNPA2/B1-stress granules dynamics to inhibit perioperative neurocognitive disorders in aged mild cognitive impairment rats
敲低 RUVBL2 可改善 hnRNPA2/B1 应激颗粒动力学,从而抑制老年轻度认知障碍大鼠围手术期神经认知障碍
Electroacupuncture alleviates Parkinson's disease by targeting HDAC/SIRT-mediated deacetylation of 14-3-3.
电针疗法通过靶向 HDAC/SIRT 介导的 14-3-3 去乙酰化来缓解帕金森病。
Folic acid ameliorates placental structure and function in fetal growth restriction via epigenetic modifications.
叶酸通过表观遗传修饰改善胎儿生长受限时的胎盘结构和功能。
Electroacupuncture combined with HDAC1 inhibitor suppress tumor growth via improving the recruitment of intratumor CD8+ T cells for triple-negative breast cancer in mice
电针联合HDAC1抑制剂可通过促进肿瘤内CD8+ T细胞的募集来抑制小鼠三阴性乳腺癌的肿瘤生长。
- 1
- 2
- 3
- 4
- 5
- 6
- 7